Table 2.
Overall cohort (n = 217) | |
---|---|
Hematology | |
Total WBC∗, number × 109/L (IQR) | 7.10 (6.18–8.30) |
Neutrophils, number × 109/L (IQR) | 4.54 (3.55–5.46) |
Lymphocytes, number × 109/L (IQR) | 1.77 (1.42–2.15) |
Monocytes, number × 109/L (IQR) | 0.44 (0.35–0.55) |
Platelets, number × 109/L (IQR) | 229 (189.50–276.50) |
Red blood cells, number × 1012/L (IQR) | 4.70 (4.40–4.95) |
| |
Chemistry | |
Serum total-c†, mg/dL (IQR) | 194 (165–224.25) |
Serum LDL-c‡, mg/dL (IQR) | 114.90 (88.20–142.75) |
Serum HDL-c§, mg/dL (IQR) | 49 (41.25–61.75) |
Serum TAG‖, mg/dL (IQR) | 118 (90–162.25) |
Fibrinogen, mg/dL (IQR) | 3.69 (3.15–4.24) |
Fasting glycemia, mg/dL (IQR) | 101 (91–115.75) |
hs-CRP#, μg/mL (IQR) | 2.38 (0.90–4.95) |
IL-6∗∗, pg/mL (IQR) | 2.16 (0.68–3.83) |
Data are expressed as median (interquartile range [IQR]) or number (percentages [%]).
∗WBC: white blood cells.
†Total-c: total cholesterol.
‡LDL: low-density lipoprotein.
§HDL: high-density lipoprotein.
‖TAG: triglycerides.
#hs-CRP: high sensitivity c-reactive protein.
∗∗IL: interleukin.